Overview

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Status:
RECRUITING
Trial end date:
2028-03-15
Target enrollment:
Participant gender:
Summary
This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib, or placebo. Participants will have an Xray, knee MRI, brain MRI, blood draws, pain sensitivity testing, and asked to fill out questionnaires. The purpose of this study is to try to predict which participants will respond to the treatment.
Phase:
PHASE4
Details
Lead Sponsor:
Northwestern University
Collaborator:
Brigham and Women's Hospital
Treatments:
Celecoxib
Duloxetine Hydrochloride